Clinical Trial Update: EO4010 in Previously Treated Metastatic Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

The EO4010 trial in previously treated metastatic colorectal cancer (Phase 1/Phase 2) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EO4010

Snippet

Sponsor: Enterome | Conditions: Colorectal Cancer Metastatic | Phase 1, Phase 2 | Status: TERMINATED